Diluted EPS came in at $-0.16, beat the $-0.24 consensus by $0.08.
Trailing eight quarters through Q3 2024
Common questions about Pulse Biosciences, Inc.'s Q3 2024 earnings report.
Pulse Biosciences, Inc. (PLSE) reported Q3 2024 earnings on October 30, 2024 after market close.
Pulse Biosciences, Inc. reported diluted EPS of $-0.16 for Q3 2024.
EPS beat the consensus estimate of $-0.24 by $0.08.
You can read the 10-Q periodic report (0001437749-24-032614) directly on SEC EDGAR. The filing index links above go to sec.gov.